213 results on '"Choy, Anna Maria"'
Search Results
2. Blood-based and Imaging Biomarkers of Atherosclerosis
3. Accelerated elastin degradation by age-disease interaction: a common feature in age-related diseases
4. Exaggerated elastin turnover in young individuals with Marfan syndrome: new insights from the AIMS trial
5. Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation
6. Biomarkers of Aortopathy in Marfan Syndrome
7. The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X
8. Blood-Based and Imaging Biomarkers of Atherosclerosis.
9. Prevalence and pregnant women's knowledge of maternal obesity and excessive GWG among women attending antenatal care in Fako division, Cameroon
10. Plasma desmosine for prediction of outcomes after acute myocardial infarction
11. Insulin Sensitization Therapy and the Heart: Focus on Metformin and Thiazolidinediones
12. PLASMA DESMOSINE, A BIOMARKER OF ELASTIN DEGRADATION, PREDICTS OUTCOMES IN ACUTE MYOCARDIAL INFARCTION
13. Impact of Renin-Angiotensin System Blockade Therapy on Outcome in Aortic Stenosis
14. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study
15. Prevalence and pregnant women's knowledge of maternal obesity and excessive gestational weight gain among women attending antenatal care in Fako Division, Cameroon.
16. Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
17. Underutilization of IV Nitrates in the Treatment of Acute Heart Failure
18. 5 Exaggerated elastin turnover in childhood and adolescence in marfan syndrome - correlation with age - new insights from the aims trial
19. BS7 Plasma desmosine as a biomarker in acute aortic syndrome
20. PLASMA DESMOSINE, A BIOMARKER OF ELASTIN DEGRADATION, PREDICTS OUTCOMES IN ACUTE MYOCARDIAL INFARCTION
21. Algorithm To Detect Left Ventricular Dysfunction After Myocardial Infarction [with Reply]
22. High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study
23. Adverse Psychological Effects and Costs Associated with Waiting for Radiofrequency Ablation
24. Aortic valvular heart disease: is there a place for angiotensin-converting-enzyme inhibitors?
25. Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study
26. Pacing-induced heart disease: understanding the pathophysiology and improving outcomes
27. Right ventricular pacing impairs endothelial function in man
28. Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
29. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
30. Short-Term Effect of Atorvastatin on Endothelial Function in Healthy Offspring of Parents with Type 2 Diabetes Mellitus
31. Insulin Resistance: A Potential New Target for Therapy in Patients with Heart Failure
32. Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trials
33. Coronary Vasomotor Function Is Abnormal in First-Degree Relatives of Patients With Type 2 Diabetes
34. Abnormalities of the QT interval in primary disorders of autonomic failure
35. Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans
36. Plasma Desmosine and Abdominal Aortic Aneurysm Disease
37. 126 Urinary desmosine, a biomarker of elastin degradation is significantly elevated and associated with maximum aortic root size and aortic Z-scores in patients with bicuspid aortic valve
38. A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
39. PLASMA DESMOSINE, AN ELASTIN DEGRADATION PRODUCT, PREDICTS OUTCOMES IN AT RISK POPULATIONS
40. Algorithm to detect left ventricular dysfunction after myocardial infarction: Low specificity of algorithm would lead to extensive overtreatment
41. Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
42. 6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial
43. 65 The novel plasma biomarker desmosine, a marker of elastin breakdown, is an independent predictor of abdominal aortic aneurysm events independent of aneurysm size
44. The APEX trial: Effects of allopurinol on exercise capacity, coronary and peripheral endothelial function, and natriuretic peptides in patients with cardiac syndrome X
45. Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy
46. Mean HbA1cand mortality in diabetic individuals with heart failure: a population cohort study
47. APSC2015-1235 Prolonged PR and QRS Intervals Predict Outcome in Patients With Chronic Heart Failure
48. 40 Clinical Utility of Combined Platelet Count and Neutrophil-to-Lymphocyte Ratio, a Simple Blood Test, in Predicting Outcome in Patients with Chronic Heart Failure
49. EFFECT OF GLYCAEMIC CONTROL ON OUTCOME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE
50. PROGNOSTIC ROLE OF COMBINED PLATELET COUNT AND NEUTROPHIL-TO-LYMPHOCYTE RATIO IN PREDICTING OUTCOME IN PATIENTS WITH CHRONIC HEART FAILURE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.